It inhibits the Ras/Raf/MEK/ERK signaling pathway to inhibit tumor cell proliferation, platelet-derived growth factor receptor-β, vascular endothelial growth factor (VEGF) receptor-2, and hepatocyte factor receptor (c-Kit), thereby inhibiting tumor angiogenesis [19]. Here, KIT is linked to neoplasm.